Deltorphins are endogenous linear heptapeptides, isolated from skin extracts of frogs belonging to the genus PhyUomedusa, that have a higher affinity and selectivity for 6 opioid binding sites than any other natural compound known. Two deltorphins with the sequence Tyr-Ala-Phe-Asp(or Glu)-Val-Val-Gly-NH2 have been isolated from skin extracts of PhyUomedusa bicolor. The alanine in position 2 is in the D configuration. These peptides, deltorphins I and II, show an even higher affinity for 6 receptors than the previously characterized deltorphin, which contains D-methionine as the second amino acid. These peptides show some similarity to another constituent of Phylomedusa skin, dermorphin, which is highly selective for ,u-opioid receptors. These peptides all have the N-terminal sequence Tyr-D-Xaa-Phe, where D-Xaa is either D-alanine or D-methionine. While this structure seems to be capable of activating both pA and 6 opioid receptors, differences in the C-terminal regions of these peptides are probably responsible for the observed high receptor selectivity of dermorphin and deltorphin.
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The endogenous opioid ligands isolated from vertebrate brain show little selectivity toward the different types of opioid receptors. Peptides isolated from amphibian skin appear to be more selective. In 1981 Montecucchi et al. (1) extracted from the skin of the Argentinian frog Phyllomedusa sauvagei a heptapeptide named dermorphin, which preferentially binds to A-type opioid receptors (2) . By recombinant DNA techniques, it was demonstrated that dermorphin, like numerous other peptides, is derived in multiple copies from larger precursors. In addition, from inspection of the sequence of one of the cloned cDNAs for these precursors, the existence of another heptapeptide with an N-terminal region similar to that of dermorphin was predicted (3) . We recently succeeded in isolating small quantities of this peptide from the skin ofP. sauvagei and named it deltorphin, because of its high affinity and selectivity for the 8 opioid binding site (4) . Both dermorphin and deltorphin contain a D amino acid (D-alanine and D-methionine, respectively) as the second amino acid. In the cloned cDNAs, codons for the corresponding L amino acids-i.e., GCG for alanine and ATG for methionine-were found at these positions. This characteristic suggested that the processing of these peptides includes a reaction whereby an L amino acid residue is converted to its D isomer within peptide linkage (3) . Here we describe the isolation of two other heptapeptides from the skin of Phyllomedusa bicolor, which show an affinity and selectivity for 8 opioid receptors several times higher than that of deltorphin and the cyclic enkephalin derivative [D-Pen2,D-Pen5]enkephalin (DPDPE, where D-Pen is D-penicillamine) (5) . Once again, these peptides contain a D-alanine residue in the second position and share with dermorphin and deltorphin the N-terminal sequence Tyr-D-Xaa-Phe. We refer to these peptides, which differ by the presence of an aspartic or glutamic residue in position 4 After centrifugation at 100,000 x g for 5 min the supernatant was directly injected into a reversed-phase HPLC column for peptide quantification. bicolor. Eluates were tested for opioid activity on the mouse vas deferens preparation. The active fractions (Fig. 1B) were used for sequence analysis. Automated Edman degradation of these two peptides gave the sequences Tyr-Ala-PheGlu-Val-Val-Gly (peak 1, 45.6 min) and Tyr-Ala-Phe-AspVal-Val-Gly (peak 2, 46.1 min), which were consistent with the corresponding amino acid compositions Glul.oGlyl.oAla0.*Vall.8Tyro.8Phe1.0 (peak 1) and Asp0.8Gly1.0Ala0.9Val1.7-Tyr0.7Phe1.0 (peak 2). To test whether these peptides terminate with a free carboxyl group or an amide, 10 nmol of each peptide was sequenced by manual dansyl Edman degradation. After the sixth cycle of degradation (i.e., after removal of the penultimate valine), the sample was reacted with dansyl chloride and an aliquot was directly analyzed without previous acid hydrolysis. The presence of a fluorescent compound with chromatographic characteristics identical to those of a sample of authentic dansylglycinamide was detected by both thin-layer chromatography on polyamide sheets and reversed-phase HPLC. A second aliquot of the sample was similarly analyzed after acid hydrolysis and showed the presence of dansylglycine.
The L or D configuration of the alanine residue in these peptides was demonstrated by incubating aliquots of the acid hydrolysates with D-amino acid oxidase. Amino acid analysis revealed the disappearance of alanine in the samples subjected to the enzymatic treatment. Thus, both peptides contain D-alanine in position 2 and a C-terminal glycinamide. Deltorphins are almost inactive on guinea pig ileum and rat vas deferens (A site), as well as on rabbit vas deferens (K site).
On the other hand, on guinea pig ileum, dermorphin showed an IC50 value in the nanomolar range, which was 17 times lower than that on mouse vas deferens, confirming its preferential binding to the ,u opioid receptor sites.
The binding isotherm for [D-Ala2]deltorphin I with rat brain membranes (Fig. 2) Deltorphins are more flexible linear peptides than the conformationally restricted cyclic peptide DPDPE. Nevertheless, they showed an affinity for 8 sites from 10 to 200 times higher than that of the synthetic enkephalin analogue. Thus, the suggestion that the highest level of selectivity toward a given opioid binding site may be achieved only by imposing conformational restrictions on peptide chains is not supported by these observations. The high affinity and potency of the deltorphins could allow the precise biochemical and pharmacological characterization of the 6 indicate that the value of log Ki was greater than could be measured. to date. Since amphibian skin peptides are often similar or even identical to mammalian hormones and neurotransmitters (18), the question whether relatives of the dermorphin/ deltorphin peptides also occur in mammals clearly deserves further attention.
